
What Conditions Can Mimic ALS?
ALS is a neurodegenerative disorder characterized by the progressive loss of motor neurons in the brain and spinal cord, leading to muscle weakness and atrophy.
However, several diseases mimic ALS due to overlapping symptoms, making an accurate diagnosis challenging. It can take more than a year to arrive at an accurate ALS diagnosis.
Read on to learn more about diseases that mimic ALS, including how doctors distinguish between them and ALS.
Symptoms of ALS
Common ALS symptoms include:
muscle weakness
muscle atrophy
twitching
muscle stiffness
difficulty swallowing (dysphagia)
difficulty speaking (dysarthria)
breathing problems
fatigue
Myasthenia gravis
Myasthenia gravis (MG) is a neuromuscular disorder that can mimic ALS due to shared symptoms like muscle weakness. However, there are distinct differences.
MG typically features fluctuating muscle weakness that worsens with use, often starting in the eye muscles.
Doctors distinguish MG from ALS through specialized tests like repetitive nerve stimulation, which reveals a characteristic decrease in muscle response. Blood tests can also detect acetylcholine receptor or muscle-specific kinase antibodies, indicating MG.
Unlike ALS, which is progressively debilitating with no cure, MG has effective treatments like acetylcholinesterase inhibitors or immunosuppressive medications.
Multiple sclerosis
Multiple sclerosis (MS) is another neurological condition that can sometimes be mistaken for ALS due to overlapping symptoms. It typically presents with episodes of neurological dysfunction that come and go (relapsing-remitting), while ALS involves progressive, steady motor neuron degeneration.
Diagnostic tools like MRI can reveal characteristic MS lesions in the central nervous system, helping to distinguish between the two conditions. Cerebrospinal fluid analysis can also help a doctor distinguish MS from ALS.
Unlike ALS, MS has disease-modifying therapies to manage symptoms and slow its progression.
Other motor neuron disorders
Several motor neuron disorders mimic ALS, including:
Primary lateral sclerosis (PLS): PLS is a rare motor neuron disorder characterized by progressive weakness, stiffness, and spasticity in the limbs. But unlike ALS, PLS primarily affects your upper motor neurons.
Progressive muscular atrophy (PMA): PMA affects your lower motor neurons, resulting in muscle weakness and wasting. This is similar to ALS but without the upper motor neuron involvement often seen in ALS.
Hereditary spastic paraplegia (HSP): This group of genetic disorders causes spasticity and weakness, often starting in the lower limbs. While it shares spasticity with ALS, it doesn't involve motor neuron degeneration.
Kennedy's disease: This rare genetic disorder primarily affects the bulbar and spinal regions, causing muscle weakness and atrophy. It can resemble ALS but has distinct genetic markers. It's an X-linked condition, meaning it affects mostly males.
Key terms
Motor neuron degeneration affects how nerves control muscles. Nerve cells stop sending signals from the brain and spinal cord to the muscles, leading to muscle waste. As it progresses, it can affect other body functions, like speaking or swallowing.
Spasticity, a symptom of motor neuron disorders, means tightness or stiffness and can cause uncontrollable movements.
Upper motor neurons originate in the brain, more specifically in the cerebral cortex, and travel down to the spinal cord. Lower motor neurons begin in the spinal cord and then travel down to the muscles.
Infections like Lyme disease and HIV can present symptoms that mimic ALS.
Lyme disease can lead to neurological symptoms such as muscle weakness and spasticity. Distinguishing it from ALS involves a detailed medical history and blood tests for Lyme antibodies.
HIV-associated neurological complications, including motor dysfunction, can also mimic ALS. Differentiating between the two depends on HIV testing and other HIV-related symptoms.
Hyperthyroidism
Hyperthyroidism can mimic ALS symptoms due to muscle weakness, tremors, and weight loss. Doctors can use thyroid function tests to reveal elevated thyroid hormone levels to differentiate hyperthyroidism from ALS.
Effective treatment for hyperthyroidism, such as antithyroid medications or radioactive iodine, can resolve symptoms.
Vitamin B12 deficiency
Vitamin B12 deficiency can cause neurological symptoms resembling ALS, including muscle weakness and numbness. Blood tests revealing low B12 levels confirm the deficiency.
Vitamin B12 supplementation can reverse these symptoms, distinguishing it from the irreversible progression of ALS.
Post-polio syndrome
Post-polio syndrome can mimic ALS, leading to muscle weakness and fatigue. A history of prior polio infection and electromyography (EMG) findings help differentiate it from ALS.
Unlike ALS, the weakness in post-polio syndrome is generally stable, and management involves rehabilitation strategies to improve function.
Nerve damage
Spinal cord compression (myelopathy) or a pinched nerve (radiculopathy), particularly in the neck or lower back, can also cause symptoms similar to ALS. They can also present similar findings on certain diagnostic tests, like EMG.
In addition to motor symptoms, radiculopathy also causes sensory loss and neuropathic pain. These symptoms are not commonly seen in ALS. Also, in contrast to ALS, myelopathy can cause severe neck pain and loss of control of the anal sphincter.
How do doctors either confirm or rule out ALS?
Doctors use a combination of clinical evaluations to assess your medical history and symptoms, looking for signs characteristic of ALS. They can also use diagnostic tests to either confirm or rule out ALS, including:
EMG and nerve conduction studies: These tests measure electrical activity in muscles and nerves. In ALS, EMG often shows signs of muscle denervation and twitching.
MRI and CT scans: Imaging studies can help doctors rule out other diseases that mimic ALS. While they can't confirm ALS, they can indicate muscle atrophy or structural abnormalities.
Blood tests: Doctors use blood tests to rule out conditions with similar symptoms, such as thyroid disorders or infections. ALS itself doesn't have specific blood markers.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Associated Press
37 minutes ago
- Associated Press
Stop Gas Station Heroin Coalition Commends FDA Crackdown on Illegal Drug '7'
Agency enforcement targets lab-made analogs, protecting consumers from unapproved new drugs The Stop Gas Station Heroin coalition today commended the U.S. Food and Drug Administration (FDA) for issuing warning letters to companies marketing '7" — a dangerous semi-synthetic alkaloid often disguised as a natural dietary supplement. This action marks a critical step toward curbing the spread of " Gas Station Heroin " — a term used to describe a range of often imported lab-made substances that include tianeptine, nitrous oxide, semi-synthetic and synthetic alkaloid products, and intoxicating hemp products. 7-hydroxymitragynine (7-OH) is only naturally present in trace amounts in dried kratom leaves. Bad actors synthetically mass produce high-concentration, ultra-potent 7-OH isolates in tablets, capsules, powders, and gummies. These chemically manipulated products are misleadingly marketed as natural dietary supplements or food. In reality, they act like prescription opioids and not botanicals, posing serious health risks such as respiratory depression, addiction, and overdose. The FDA's warning letters underscore what scientists and public health experts have long known: Gas Station Heroin products are not supplements. They are unapproved, mislabeled street drugs designed to mimic the effects of opioids and other narcotics. As the FDA notes, Gas Station Heroin products are often aggressively advertised online and in retail locations with deceptive claims about their safety and effectiveness, particularly to individuals seeking to get high or prescription alternatives for pain relief, anxiety, or opioid withdrawal. Stop Gas Station Heroin applauds the FDA for using its enforcement authority to hold these illicit companies accountable and to protect American consumers from the growing threat posed by synthetic drugs. About Stop Gas Station Heroin Stop Gas Station Heroin is a national coalition that aims to educate consumers about harmful synthetic drugs and advocate for smart regulation that distinguishes between legitimate, natural botanicals and dangerous, synthetic drugs, combined with enforcement of current federal laws around unapproved drugs. To learn more, navigate to Media Contact Colby Wilson [email protected] ### SOURCE: Stop Gas Station Heroin Copyright 2025 EZ Newswire

Associated Press
37 minutes ago
- Associated Press
Dr. Stephen Courtney Performs World's First Procedure Using Eminent Spine's Groundbreaking 3D-Printed Pedicle Screw
Plano, TX July 16, 2025 --( )-- Eminent Spine, a leading innovator in spinal implant technologies, is proud to announce a major surgical milestone: Dr. Stephen Courtney has successfully completed the world's first spinal procedure using the company's revolutionary 3D-printed pedicle screw system. This groundbreaking case marks a new era in spinal surgery, combining precision engineering with advanced additive manufacturing. Dr. Courtney, a board-certified orthopedic spine surgeon and founder of Eminent Spine, performed the historic procedure at Eminent Hospital in Richardson, Texas. Known for his commitment to innovation and patient outcomes, Dr. Courtney utilized the new 3D pedicle screw system to treat a patient with degenerative lumbar pathology requiring spinal stabilization. The 3D-printed screw, designed and manufactured by Eminent Spine, is the first of its kind to enter clinical use. Built using proprietary lattice technology, the screw optimizes bone ingrowth, enhances mechanical stability, and improves fixation in both normal and compromised bone quality. This next-generation implant represents a leap forward in spinal hardware by improving osseointegration while reducing the potential for loosening or migration over time. This implant truly is the Future of Fusion. Eminent Spine's 3D screw is part of a broader portfolio expansion that includes innovative solutions across the cervical, thoracolumbar, and sacroiliac (SI) regions. With FDA clearance and full commercialization underway, the company expects growing surgeon adoption across the U.S. For more information about Eminent Spine and its new 3D-printed pedicle screw system, visit or email [email protected]. About Eminent Spine: Eminent Spine is a privately held medical device company committed to delivering innovative, cost-effective spinal implant solutions. Founded by spine surgeons, the company designs its products with a deep understanding of both surgical challenges and patient needs. Contact Information: Eminent Spine Dagen Hybner 972-499-3593 Contact via Email For distribution information contact Michael McDonough: [email protected] Read the full story here: Dr. Stephen Courtney Performs World's First Procedure Using Eminent Spine's Groundbreaking 3D-Printed Pedicle Screw Press Release Distributed by

Associated Press
37 minutes ago
- Associated Press
Kratom Consumer Advisory Council (KCAC) Releases White Paper Debunking Claims on Safety of '7' Products
New analysis calls out misinformation, urges public health protections from dangerous 7-hydroxymitragynine (7-OH) formulations Kratom Consumer Advisory Council (KCAC) today released a comprehensive white paper challenging recent claims that products containing isolated 7-hydroxymitragynine (also known as '7') are safe for widespread, uncontrolled consumer use. The white paper, " Have '7' Products with 7-Hydroxymitragynine (7-OH) Been Proven to Be Safe? " directly refutes assertions made in a July 7 press release by the Holistic Alternative Recovery Trust (HART), which KCAC says misrepresented findings from a report HART itself commissioned from healthcare consulting firm Marwood Group. KCAC Chair Dr. C. Michael White, Pharm.D., FCP, FCCP, FASHP, and Distinguished Professor of Pharmacy Practice at the University of Connecticut, issued a stark warning: 'It is dangerously misleading to suggest that 7 products are safe for public sale without medical oversight. Marwood Group's own report, despite being commissioned by HART, clearly concludes that synthetic 7-hydroxymitragynine is a potent opioid agonist with high abuse potential, rapid tolerance development, and physical dependence in animal models. HART's attempt to erase key parts of the report after publication, including these risk statements, is an alarming act of public deception that endangers consumers.' The KCAC white paper cites the following key concerns from the Marwood Group report that HART initially published and then quietly removed: The KCAC paper refutes Marwood Group's assertion that 7-hydroxymitragynine has a lower risk of respiratory depression. They used a surrogate marker called beta-arrestin recruitment to say the risk was lower without looking at actual animal studies where breathing was assessed and shown to be depressed, just like with morphine. It also provides a balanced perspective on anecdotal experiences with 7 products where consumers report widespread recreational use for euphoria and suffering from severe addiction. 'We've seen this playbook before, downplaying the risks of potent opioids while encouraging unregulated use. The opioid crisis of the 2000s began with similar false assurances,' said Dr. White. 'We must not repeat history with synthetic 7-hydroxymitragynine. These products must be evaluated through rigorous clinical trials and carefully controlled, not sold like candy at gas stations.' The white paper also highlights KCAC's support for the FDA's July 15 warning letters against firms illegally marketing synthetic 7-hydroxymitragynine products and making unsubstantiated medical claims. KCAC calls on regulators, lawmakers, and the media to take a clear-eyed view of the risks posed by synthetic 7-hydroxymitragynine products and urges a halt to the sale of these potent synthetic derivatives outside of clinical or research settings. The full white paper, 'Have '7' Products with 7-Hydroxymitragynine (7-OH) Been Proven to Be Safe?' is available here. About Kratom Consumer Advisory Council (KCAC) Kratom Consumer Advisory Council (KCAC) is an independent board made up of a clinician-scientist and consumers that uses the strongest available evidence to produce position statements that promote evidence-based policy. The KCAC is supported by the Global Kratom Coalition which advocates for regulations that protect consumers and curbs the sale of adulterated or synthetic products falsely marketed as kratom. For more information, visit Media Contact Dr. C. Michael White [email protected] ### SOURCE: Kratom Consumer Advisory Council (KCAC) Copyright 2025 EZ Newswire